-
M650053-5mgMizacorat (AZD9567: compound 15) is a potent, oral active, non-steroidal and selective glucocorticoid receptor modulator (SGRM) , with an IC 50 of 3.8 nM. Exhibits excellent efficacy in the streptococcal cell wall (SCW) reactivation model of joint
-
M656113-1mlMizacorat (AZD9567: compound 15) is a potent, oral active, non-steroidal and selective glucocorticoid receptor modulator (SGRM) , with an IC 50 of 3.8 nM. Exhibits excellent efficacy in the streptococcal cell wall (SCW) reactivation model of joint
-
N129302-1gAnti-inflammatory, anti-bacterial. A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase.
-
N129302-250mgAnti-inflammatory, anti-bacterial. A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase.
-
N129302-25gAnti-inflammatory, anti-bacterial. A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase.
-
N129302-5gAnti-inflammatory, anti-bacterial. A non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase.
-
-
-
-
N425941-1mlAn analgesic selective inhibitor of COX-2.
-
O646711-10mgOpiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) , with IC 50 s of 0.86 and 1.3 μM, respectively. Opiranserin
-
O646711-25mgOpiranserin (VVZ-149) hydrochloride, a non-opioid and non-NSAID analgesic candidate, is a dual antagonist of glycine transporter type 2 (GlyT2) and serotonin receptor 2A (5HT2A) , with IC 50 s of 0.86 and 1.3 μM, respectively. Opiranserin